Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone treatment on 2D and 3D-cultured skin cells slows down hair growth by affecting certain genes and could be a potential target for hair loss treatment.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Dutasteride and finasteride affect different cell types differently.

Stem cells preservation in AGA could be a potential therapy, but more cases needed.

Hair loss in Androgenetic Alopecia is not caused by damage to follicular stem cells.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Effective PCOS treatments require targeting specific signaling pathways.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Male hormones control a specific gene in hamster skin, with different hormones having varying effects.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Male hair loss is caused by inactive hair follicle stem cells.

Human hair follicle cells can grow hair when put into mouse skin if they stay in contact with mouse cells.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Hair loss needs more research for better treatments.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.